Search
Blog Post
Women in Science: Emese Zsiros MD, PhD
Blog Post
Cancer Innovations: Prioritizing quality of life while treating cancer
Blog Post
Why women with ovarian cancer should consider clinical trials
… better options,” explains gynecologic oncologist Emese Zsiros, MD, PhD, FACOG, of Roswell Park Comprehensive Cancer … for patients who have tried every other option,” says Dr. Zsiros. “Some of the most important clinical trials are … can make informed decisions about their care,” says Dr. Zsiros. Orsolina Sepe enrolled in a clinical trial after …
Blog Post
Cancer Innovations: New initiative reduced prescribed opioids by 45%
… recovery. How would patients fare without opioids? Emese Zsiros, MD, PhD, FACOG, a gynecologic oncologist at Roswell … based on their clinical experience. The results? Dr. Zsiros says the number of opioids prescribed to these … in the fight against the ongoing opioid epidemic.” Dr. Zsiros and her team reported the results from the first six …
Clinical Trial
A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY FOR LNCB74, A B7-H4 TARGETED ANTIBODY DRUG CONJUGATE, AS MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
Clinical Trial
A Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety and Tolerability of GB-5267, an IL-18 Armored CAR T Cell Product Targeting MUC16, in Patients with Platinum-Resistant Ovarian Cancer
… in Patients with Platinum-Resistant Ovarian Cancer I Zsiros, Emese This phase 1 study evaluates the safety, …
Clinical Trial
NRG-GY032: A Phase II Study of Tailored Adjuvant Therapy in Pole-Mutated and p53-Wildtype/NSMP Early-Stage Endometrial Cancer (RAINBO BLUE & TAPER)
Blog Post
Does your gut biome affect your response to immunotherapy?
Clinical Trial
Randomized Phase 2 Clinical Trial of Pembrolizumab Combined with Bevacizumab with or without Agonist Anti-CD40 CDX-1140 in Patients with Recurrent Ovarian Cancer
Blog Post